Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics Inc AKBA
News
-
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
Akebia Shares Rally Premarket After FDA Approves Vafseo
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
Thinking about buying stock in Akebia Therapeutics, Boeing, Aquestive Therapeutics, General Electric, or Canoo?
Thinking about buying stock in SoundHound AI, Aquestive Therapeutics, Akebia Therapeutics, Kaival Brands, or Lufax?
Thinking about buying stock in MicroCloud Hologram, Akebia Therapeutics, Mind Medicine, Treasure Global, or Getty Images?
Thinking about buying stock in 2Seventy Bio, Verb Technology, Exscientia, MicroCloud Hologram, or Akebia Therapeutics?
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thinking about buying stock in Fusion Fuel Green, Tarena International, Ocugen, Akebia Therapeutics, or Abeona Therapeutics?
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thinking about buying stock in Alibaba Group, Akebia Therapeutics, Plug Power, AMC Entertainment, or C4 Therapeutics?
Thinking about buying stock in Kura Oncology, Akebia Therapeutics, American Airlines, Evaxion Biotech, or Minim?
Akebia Secures $55 Million Term Loan Financing
Akebia: FDA Accepts Resubmission of Vadadustat Application
Akebia Therapeutics Shares Rise 13% After FDA Letter for Vadadustat